Two New Classes of Drugs to Target Chemotherapy Resistant and High Risk B-ALL

Cathy A. Swindlehurst; Leah Fung; Kyle W.H. Chan; Sabine Ottilie; Ashkan Shahbandi; Christopher L. Morris; Oliva L Francis; Terrence Bennet; Shannalee R Martinez; Kimberly J Payne

doi:10.1182/BLOOD.V118.21.2590.2590

Two New Classes of Drugs to Target Chemotherapy Resistant and High Risk B-ALL

Cathy A. Swindlehurst
, Leah Fung
, Kyle W.H. Chan
, Sabine Ottilie
, Ashkan Shahbandi
, Christopher L. Morris
, Oliva L Francis
, Terrence Bennet
, Shannalee R Martinez
, Kimberly J Payne

Loma Linda University

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	118
DOIs	https://doi.org/10.1182/BLOOD.V118.21.2590.2590
State	Published - Nov 18 2011

Disciplines

Biology
Pharmacology

Access to Document

10.1182/BLOOD.V118.21.2590.2590License: Unspecified

OpenUrl availability

Full text

Cite this

@article{89f89cc859aa4371b3596110414143f3,

title = "Two New Classes of Drugs to Target Chemotherapy Resistant and High Risk B-ALL",

author = "Swindlehurst, \{Cathy A.\} and Leah Fung and Chan, \{Kyle W.H.\} and Sabine Ottilie and Ashkan Shahbandi and Morris, \{Christopher L.\} and Francis, \{Oliva L\} and Terrence Bennet and Martinez, \{Shannalee R\} and Payne, \{Kimberly J\}",

note = "Abstract. Abstract 2590Survival remains less than 50\% for children and young adults with relapsing acute lymphoblastic leukemia (ALL). Increases in ALL surviva",

year = "2011",

month = nov,

day = "18",

doi = "10.1182/BLOOD.V118.21.2590.2590",

language = "American English",

volume = "118",

journal = "Blood",

}

TY - JOUR

T1 - Two New Classes of Drugs to Target Chemotherapy Resistant and High Risk B-ALL

AU - Swindlehurst, Cathy A.

AU - Fung, Leah

AU - Chan, Kyle W.H.

AU - Ottilie, Sabine

AU - Shahbandi, Ashkan

AU - Morris, Christopher L.

AU - Francis, Oliva L

AU - Bennet, Terrence

AU - Martinez, Shannalee R

AU - Payne, Kimberly J

N1 - Abstract. Abstract 2590Survival remains less than 50% for children and young adults with relapsing acute lymphoblastic leukemia (ALL). Increases in ALL surviva

PY - 2011/11/18

Y1 - 2011/11/18

UR - https://ashpublications.org/blood/article/118/21/2590/70359/Two-New-Classes-of-Drugs-to-Target-Chemotherapy

U2 - 10.1182/BLOOD.V118.21.2590.2590

DO - 10.1182/BLOOD.V118.21.2590.2590

M3 - Article

VL - 118

JO - Blood

JF - Blood

ER -

Two New Classes of Drugs to Target Chemotherapy Resistant and High Risk B-ALL

Disciplines

Access to Document

OpenUrl availability

Other files and links

Cite this